Community resources and publications

TAG hepatitis C pipeline report

Tracy Swan’s 2011 Hepatitis C Treatment Pipeline Report produced by the Treatment Action Group in New York is a must-read. This clear concise and comprehensive overview of research shows that hepatitis C treatments in 2011 have a similarly dramatic potential as HAART had for HIV in 1996.

Issues covered include diagnostics, drug resistance,  access to, and delivery of treatment, and population-specific focus on the new HCV drugs, as well as research recommendations.

FDA approval of two hepatitis C-specific protease inhibitors, the first of the coming wave of oral antiviral drugs, is anticipated later this year. Dozens of other drugs are in development.


Links to other websites are current at date of posting but not maintained.